Live Breaking News & Updates on Mologic Ltd|Page 9
Stay updated with breaking news from Mologic ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Foresight VCT plc - Annual Financial Report FORESIGHT VCT PLC 31 December 2020 Foresight VCT plc, managed by Foresight Group LLP, today announces the final results for the year ended 31 December 2020. These results were approved by the Board of Directors on 9 April 2021. The Annual Report will shortly be available in full at www.foresightgroup.eu. All other statutory information can also be found there. Highlights The portfolio has seen an uplift in valuation of £4.8 million during the year. Net Asset Value per share decreased by 3.7% from 76.5p at 31 December 2019 to 73.7p. Including the payment of a 3.3p dividend made on 19 June 2020, NAV total return per share at 31 December 2020 was 77.0p, representing a positive total return of 0.7%. ....
Feb 14 2021 Read 3006 Times The University of Liverpool and Mologic Ltd have been collaborating on a lateral flow test which will allow farmers and vets to diagnose livestock exposure to fluke on farm, with results available within 10 minutes. Prevalent in over 70 countries worldwide and a common parasite affecting cattle and sheep in the UK, Fasciola hepatica (the liver fluke) is estimated to cause over US 3.2 billion dollars in livestock production losses. Professor Diana Williams and Tessa Walsh PhD, Infection Biology at the University of Liverpool jointly commented: “We are delighted that what started as a research tool is now being developed as a practical diagnostic test for farmers and vets, to support strategic control for this common, devastating disease. The project has been supported by AHDB and BBSRC to bring it to a point where we can start to develop the test commercially.” ....
January 12, 2021 BEDFORDSHIRE, UK December 24, 2020 Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, is pleased to announce its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM). The test will provide health professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs, within 10 minutes. Development and validation were supported by the Wellcome Trust and the Foreign, Commonwealth and Development Office (FCDO) Joint Initiative on Research in Epidemic Preparedness and Response. The urgency for affordable diagnostics that are quality assured has been highlighted by the need to free people from quarantine and enable travel, commented professor Sanjeev Krishna, St George s University of London. Working within a consortium with Mologic and academic partners has been one of the most ef ....
Omega Notes CE Mark For Mologic s Rapid Covid-19 Test Thu, 24th Dec 2020 13:00 (Alliance News) - Omega Diagnostics Group PLC on Thursday said Mologic Ltd has received a CE mark for its professional-use Covid-19 rapid antigen test. Back in June, the London-listed medical diagnostics company signed a material transfer agreement with Mologic providing access to raw materials and know-how to manufacture the lateral flow antigen test. The test will provide healthcare professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs. As announced at its interim results in November, Omega has now established its technology transfer team and looks forward to giving an update in the new year on how the technology transfer and CE Mark is going, so the company can sell the rapid test under Omega s Visitect brand. ....
A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....